FTSE News: FTSE 100, FTSE 250, and FTSE 400 investment news
FTSE market news from the London Stock Exchange: FTSE 100, FTSE 250, and FTSE 400

Latest FTSE News:

  • Miners gain, house builders see declines

  • Oil, miners higher in London

  • Telecoms, retailers see gains

  • Pharma lower in London

  • British Energy drops on nuclear plant delays

  • Home builders see gains in London

  • House builders, property developers down in London

  • Brewers higher on bids rumors

  • Oil sector, banks mixed in London

  • BP, Royal Dutch Shell gain on higher oil prices

  • FTSE news feed

    Recommended equities news sites

  • Eurofirst News
  • Tokyo Market News
  • NYSE News
  • Insurance: Car & Home
  • FTSE
  • London Stock Exchange
  •  

    March 13, 2006

    London markets up on average volumes

    Filed under: Companies, BAA, Lonmin, Vodafone, AstraZeneca, London Stock Exchange, Sinclair Pharma

    Bid rumors took the London equities markets higher on the day on Monday, as the FTSE 100 closed at 5,952.8, a gain of 0.8 percent and very near a five-year high. The FTSE 250 was also up on the day, by 1.7 percent to 9,591.8. Volume for the day was 3.5 billion shares traded.

    In the telecommunications sector, Vodafone gained 4 percent to 129¾p. Depending on who was talking, the gain came either on an approach from a group of private equity companies or an informal bid from Verizon to purchase Vodafone’s 45 percent stake in Verizon wireless.

    In metals, platinum miner Lonmin gained 8.6 percent to £24.54 as rumors continued that Russia’s largest gold miner, Polyus Gold, was thinking of offering for the company.

    Airports operator BAA was up 2 percent to 830p on a report that Australian company Macquarie was interested in bidding for the company and was in talks with other companies on a possible joint offer.

    In the mergers and acquisitions rumor gaining the most attention, the London Stock Exchange gained 30.6 percent to £11.49 on the possibility that Nasdaq’s offer for the LSE on Friday evening could be the start of a bidding war between Nasdaq and the NYSE group for the London exchange.

    Elsewhere, pharmaceuticals group AstraZeneca was up 2.3 percent to £29.45 on positive test results for the company’s anti-cholestrol drug, Crestor. Sinclair Pharma was also up on the day, by 6.9 percent to 136p on the news that it had lowered its operating losses in 2005 and that it has raised the money to bid for French pharmaceutical company Groupe CS Dermatologie.





    Latest Equities News:

  • Wall Street ends lower despite rate cut

  • Asia-Pacific, Europe equities see declines

  • Hang Seng adds 10.72 percent on session

  • India’s Sensex drops 1,408 points on session

  • Australian markets drop for 9th straight day

  • Taiex gains on opposition win in parliamentary elections

  • Hang Seng drops nearly 400 points

  • Most Asia-Pacific markets drop on US recession worries

  • Tokyo declines on export worries

  • Asia-Pacific equities mixed on economic concerns

  • FTSE News copyright 2005 Central Consultants